In 2003 we continue to represent more venture-backed companies in the eastern U.S. than any other law firm in the country. Representative transactions to date include the following:

• Acopia Networks — $30 million
• Alnylam Pharmaceuticals — $24.6 million
• Ammasso — $10 million
• Angiolink — $13.6 million
• Ardais — $13.4 million
• Axiowave Networks — $45 million
• BioVex — $28 million
• Blue Agave Software — $6 million
• Compound Therapeutics — $12 million
• Critical Therapeutics — $56 million
• Deploy Solutions — $21 million
• EM4 — $8 million
• Endius — $26.5 million
• Evident Software — $6.8 million
• Eyetech Pharmaceuticals — $25 million
• Eziba — $3.8 million
• GenPath Pharmaceuticals — $42.7 million
• Idenix Pharmaceuticals — $255 million
• Incipient — $25 million
• IntelliVid — $5.5 million
• Jedai Broadband Networks — $10 million
• Linguagem — $10.2 million
• LiveVault — $10 million
• Momenta Pharmaceuticals — $19 million
• Nantero — $10.5 million
• Neothermia — $13.1 million
• Netezza — $20 million
• Netilla Networks — $5 million
• Optiant — $10.5 million
• Performaworks — $13 million
• Princeton eCom — $5 million
• Quallaby — $5 million
• Quantum Bridge Communications — $20 million
• Starent Networks — $23 million
• Storability — $7 million
• Tazz Networks — $10.5 million
• VistaPrint — $30 million
• Water Cove Networks — $20 million